Treatment Efficacy of Sofosbuvir and Ribavirin Combination at Two Weeks in Chronic Hepatitis C
Background:To determine the effectiveness of sofosbuvir plus ribavirin in terms of frequency of negative qualitative PCR at 2nd week of treatment in chronic hepatitis C patients with genotype 3. Methods: In this case control study 60 patients with hepatitis C who were planned to receive sofobuv...
Main Author: | Aqsa Naseer |
---|---|
Format: | Article |
Language: | English |
Published: |
Rawalpindi Medical University
2017-12-01
|
Series: | Journal of Rawalpindi Medical College |
Subjects: | |
Online Access: | https://www.journalrmc.com/index.php/JRMC/article/view/799 |
Similar Items
-
Efficacy of Combination Sofosbuvir, Pegylated-Interferon, and Ribavirin for Treatment of Hepatitis C Virus Genotype 1 Infection in Indonesia
by: Andri Sanityoso Sulaiman, et al.
Published: (2018-08-01) -
Respiratory adverse effects of Sofosbuvir-based regimens for treatment of chronic hepatitis C virus
by: Dina Abouelkheir Abdalla, et al.
Published: (2017-04-01) -
Efficacy and safety of sofosbuvir–ledipasvir for treatment of a cohort of Egyptian patients with chronic hepatitis C genotype 4 infection
by: Ahmed OA, et al.
Published: (2018-03-01) -
Hemodialysis Patients Treated for Hepatitis C Using a Sofosbuvir-based Regimen
by: Sanjay Kumar Agarwal, et al.
Published: (2017-09-01) -
Safety and efficacy of directly acting antivirals (sofosbuvir and daclatasvir) in treatment of chronic HCV in HIV-HCV co-infected Egyptian patients
by: Inas E L-Khedr Mohamed, et al.
Published: (2021-04-01)